Debbie Keresztesy

Reduced BNT162b2 Messenger RNA Vaccine Response in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Naive Nursing Home Residents

David H. Canaday, Lenore L. Carias, Oladayo A. Oyebanji et al. · Clinical Infectious Diseases · 2021 · 100 citations · Full text

Vaccination, Vaccine Development, Vaccine Target +10

COVID-19 vaccine booster dose needed to achieve Omicron-specific neutralisation in nursing home residents

David H. Canaday, Oladayo A. Oyebanji, Elizabeth M. White et al. · EBioMedicine · 2022 · 49 citations · Full text

Significant Reduction in Vaccine-Induced Antibody Levels and Neutralization Activity Among Healthcare Workers and Nursing Home Residents 6 Months Following Coronavirus Disease 2019 BNT162b2 mRNA Vaccination

David H. Canaday, Oladayo A. Oyebanji, Debbie Keresztesy et al. · Clinical Infectious Diseases · 2021 · 38 citations · Full text

Nursing Home, Immunology, Vaccine-induced Antibody Levels +17

SARS-CoV-2 Antibody Responses to the Ancestral SARS-CoV-2 Strain and Omicron BA.1 and BA.4/BA.5 Variants in Nursing Home Residents After Receipt of Bivalent COVID-19 Vaccine — Ohio and Rhode Island, September–November 2022

David H. Canaday, Oladayo A. Oyebanji, Elizabeth M. White et al. · MMWR Morbidity and Mortality Weekly Report · 2023 · 26 citations · Full text

Immunology, Immunodominance, Ba.4/ba.5 Variants +18

Does a lack of vaccine side effects correlate with reduced BNT162b2 mRNA vaccine response among healthcare workers and nursing home residents?

Oladayo A. Oyebanji, Brigid Wilson, Debbie Keresztesy et al. · Aging Clinical and Experimental Research · 2021 · 23 citations · Full text